Titan Pharmaceuticals, Inc.
Hedge Funds Holdings
Last updated:
Titan Pharmaceuticals, Inc.‘s stocks are currently a part of 14 hedge funds’ portfolios, which represents 5.23% of the total amount of its stocks outstanding. This makes up a total of 765.44K shares of Titan Pharmaceuticals, Inc.. Compared to the previous quarter, the number fell by -20.92% or -202.49K shares fewer. As for the holding position changes, 35.71% (5) of current hedge fund investors increased the number of shares held, 7.14% (1) of current holders sold a part of the shares held, and 14.29% (2) closed the holdings completely.
Hedge funds holding Titan Pharmaceuticals (Q2 2018 – Q1 2023)
| Q2 2018 | 28 |
|---|---|
| Q3 2018 | 24 |
| Q4 2018 | 24 |
| Q1 2019 | 13 |
| Q2 2019 | 14 |
| Q3 2019 | 11 |
| Q4 2019 | 15 |
| Q1 2020 | 14 |
| Q2 2020 | 17 |
| Q3 2020 | 11 |
| Q4 2020 | 10 |
| Q1 2021 | 12 |
| Q2 2021 | 11 |
| Q3 2021 | 9 |
| Q4 2021 | 12 |
| Q1 2022 | 12 |
| Q2 2022 | 13 |
| Q3 2022 | 13 |
| Q4 2022 | 21 |
| Q1 2023 | 14 |
Hedge funds changes in Titan Pharmaceuticals positions (Q2 2018 – Q1 2023)
| Q2 2018 | 5 | 3 | 7 | 5 | 8 |
|---|---|---|---|---|---|
| Q3 2018 | 8 | 4 | 3 | 12 | -3 |
| Q4 2018 | 6 | 4 | 5 | 6 | 3 |
| Q1 2019 | 11 | 0 | 1 | 21 | -20 |
| Q2 2019 | 3 | 3 | 3 | 3 | 2 |
| Q3 2019 | 4 | 1 | 4 | 7 | -5 |
| Q4 2019 | 9 | 2 | 2 | 5 | -3 |
| Q1 2020 | 4 | 7 | 1 | 4 | -2 |
| Q2 2020 | 7 | 4 | 0 | 5 | 1 |
| Q3 2020 | 1 | 1 | 2 | 7 | 0 |
| Q4 2020 | 10 | 0 | 0 | 11 | -11 |
| Q1 2021 | 5 | 4 | 2 | 3 | -2 |
| Q2 2021 | 4 | 3 | 3 | 5 | -4 |
| Q3 2021 | 3 | 1 | 3 | 5 | -3 |
| Q4 2021 | 6 | 2 | 3 | 3 | -2 |
| Q1 2022 | 4 | 3 | 1 | 4 | 0 |
| Q2 2022 | 4 | 5 | 1 | 3 | 0 |
| Q3 2022 | 4 | 2 | 4 | 4 | -1 |
| Q4 2022 | 12 | 2 | 5 | 3 | -1 |
| Q1 2023 | 0 | 5 | 1 | 2 | 6 |
Hedge funds changes in Titan Pharmaceuticals stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 176,000 | 0 |
|---|---|---|
| Q3 2018 | 4,000 | 0 |
| Q4 2018 | 6,000 | 0 |
| Q1 2019 | 1,161,000 | 184,000 |
| Q2 2019 | 1,162,000 | 211,000 |
| Q3 2019 | 185,000 | 3,000 |
| Q4 2019 | 21,000 | 0 |
| Q1 2020 | 65,000 | 0 |
| Q2 2020 | 87,000 | 0 |
| Q3 2020 | 73,000 | 0 |
| Q4 2020 | 436,000 | 113,000 |
| Q1 2021 | 1,308,000 | 999,000 |
| Q2 2021 | 367,000 | 411,000 |
| Q3 2021 | 170,000 | 36,000 |
| Q4 2021 | 717,000 | 0 |
| Q1 2022 | 632,000 | 0 |
| Q2 2022 | 1,118,000 | 0 |
| Q3 2022 | 598,000 | 0 |
| Q4 2022 | 76,870 | 0 |
| Q1 2023 | 15,790,000 | 0 |
Top 50 hedge fund holders of Titan Pharmaceuticals, Inc. (NASDAQ:TTNP)
| Hedge fund | Value | Shares owned | Portfolio share |
|---|---|---|---|
| TRUIST FINANCIAL CORP | 675K | 625.07K | 0.001% |
| JANE STREET GROUP, LLC | 333K | 27.4K | 0.000% |
| RENAISSANCE TECHNOLOGIES LLC Jim Simons | 156K | 144.71K | 0.000% |
| SIMPLEX TRADING, LLC | 129K | 10.7K | 0.000% |
| GROUP ONE TRADING, L.P. | 91K | 7.5K | 0.000% |
| VANGUARD GROUP INC | 88K | 81.92K | 0.000% |
| GEODE CAPITAL MANAGEMENT, LLC | 69K | 64.09K | 0.000% |
| STATE STREET CORP | 41K | 38.28K | 0.000% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 40K | 37.4K | 0.000% |
| VIRTU FINANCIAL LLC | 31K | 28.33K | 0.003% |
| FNY INVESTMENT ADVISERS, LLC | 30K | 28.02K | 0.021% |
| MILLENNIUM MANAGEMENT LLC Israel Englander | 19K | 17.46K | 0.000% |
| CITADEL ADVISORS LLC Ken Griffin | 14K | 13.07K | 0.000% |
| UBS GROUP AG | 12K | 11.17K | 0.000% |
| SIMPLEX TRADING, LLC | 5K | 4.8K | 0.000% |
| IFP ADVISORS, INC | 3K | 844 | 0.000% |
| LEVEL FINANCIAL ADVISORS, INC. | 1K | 987 | 0.001% |
| CITIGROUP INC | 0 | 0 | 0.000% |
| GROUP ONE TRADING, L.P. | 0 | 0 | 0.000% |
| ERGOTELES LLC | 0 | 0 | 0.000% |
| HRT FINANCIAL LP | 0 | 0 | 0.000% |